Company: MDCXW
Filing Date: 2025-11-19
Form Type: S-1
Source: 0001062993-25-016962
Chunk: 256

Company: Medicus Pharma Ltd.
Filing Date: 2025-11-19
Form: S-1
Chunk 256
---
 2025, the Company had in place a stock option plan for employee, non-employee directors, and consultants of the Company (the "Plan"). The Plan provides both for the direct award or sale of shares and for the grant of options to purchase shares. Under the plan the total number of shares available for options cannot exceed 10% of the Company's issued and outstanding common shares at the time of any grant. The Company is authorized to issue options to employees, non-employee directors and consultants under the plan.

On July 22, 2025, the Board of Directors of the Company approved the acceleration of vesting for 100,000 share options granted on December 17, 2024, 210,000 share options granted on December 17, 2024, and for 100,000 options granted on June 30, 2025, resulting in the Company recognizing $663,998 of remaining expense for such accelerated share options.

<div align='center'>F-37</div>

The following table summarizes option transactions for the Plan:

|                                   |     | Number of 
   options |   |     |       Weighted 
        average 
 exercise price 
              $ |     |         Weighted 
          average 
        remaining 
 contractual life 
          (years) |     |       Aggregate 
 intrinsic value 
               $ |
| Outstanding at December 31, 2024  |     | 1,185,000 |   |     |           1.47 |     |             4.18 |     |            1.18 |
| Granted                           |     |   825,000 |   |     |           2.99 |     |             4.81 |     |               - |
| Exercised                         |     |  (145,000 | ) |     |           1.11 |     |                - |     |               - |
| Forfeited                         |     |    (7,500 | ) |     |           2.76 |     |                - |     |               - |
| Outstanding at September 30, 2025 |     | 1,857,500 |   |     |           2.17 |     |             4.06 |     |            0.15 |
| Exercisable at September 30, 2025 |     | 1,132,500 |   |     |           1.61 |     |             3.57 |